Your Health. Your Family. Your Choice.
Administered by: Unknown Purchased by: ?
Life Threatening? No
Write-up: Severe Allergic Reaction; Developed a Severe Rash; Severe Allergic Reaction; Developed a Severe Rash; This is a spontaneous report from a contactable consumer (patient). A 58-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number: FA6780) via an unspecified route of administration in left arm on 29Jun2021 as dose 2 single for COVID-19 immunization. Patient had no medical history and was not taking any other Products. Concomitant medications of the patient were not reported. Patient previously received historical first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number: ER8735) via an unspecified route of administration on 08Jun2021 as dose 1st single for COVID-19 immunization. On 01Jul2021, 48 hours after receiving second dose of vaccination, patient experienced severe allergic reaction; developed a severe rash. Patient received treatment with Antihistamine. Outcome of the event not recovered/not resolved. Follow-up attempts are needed. Further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166